Your browser doesn't support javascript.
loading
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials.
Heerspink, Hiddo J L; Cherney, David; Gafor, Abdul Halim Abdul; Górriz, Jose Luis; Pergola, Pablo E; Tang, Sydney C W; Desch, Marc; Iliev, Hristo; Sun, Zhichao; Steubl, Dominik; Nangaku, Masaomi.
Affiliation
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Cherney D; The George Institute for Global Health, Sydney, Australia.
  • Gafor AHA; Toronto General Hospital, Toronto, Ontario, Canada.
  • Górriz JL; Faculty of Medicine, Universiti Kebangsaan Malaysia, Bangi, Malaysia.
  • Pergola PE; Department of Nephrology, University Clinical Hospital, University of València, Valencia, Spain.
  • Tang SCW; INCLIVA Research Institute, Valencia, Spain.
  • Desch M; Renal Associates PA, San Antonio, Texas.
  • Iliev H; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Sun Z; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Steubl D; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Nangaku M; Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Connecticut.
J Am Soc Nephrol ; 2024 May 25.
Article in En | MEDLINE | ID: mdl-38795055

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos